Tasly Pharmaceutical International Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Tasly Pharmaceutical International Co., Ltd. - overview

Established

1994

Location

Tianjin, -, China

Primary Industry

Pharmaceuticals

About

Founded in 1994 and based in Tianjin, China, Tasly Pharmaceutical International Co. , Ltd. operates as a manufacturer of pharmaceutical products. Tasly Pharmaceutical International is the performer of Tasly’s (Tasly Holding Group) international marketing strategy, which is running independently.


The company has established overseas branches or offices in 21 countries and regions, 4 chain Chinese medicine clinics in 4 countries, and registered more than 50 auxiliary agents, health products, functional foods and other products in more than 40 countries. The company’s main business is the international R & D, production, and sales of traditional Chinese medicine, chemical medicine, biological agents, and health food. The company’s self-developed products include a series of modern traditional Chinese medicines like Compound Danshen Dripping Pills, Yangxue Qingnao Granules, Qishen Yiqi Dripping Pills, and Yiqi Fumai products, as well as chemical medicines such as Temozolomide and Eszopiclone Tablets. The company generates revenue by supplying a variety of pharmaceutical and healthcare products and providing related healthcare services.


Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Verticals

Manufacturing

Total Amount Raised

Subscriber access only

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.